Category Archives: Rheumatology

FDA CDER Director on Benlysta for lupus and adaptive clinical trials.

July 27, 2011- Janet Woodcock, MD, Director of the FDAs new drug division, CDER, discusses with Steven Greer,

Posted in - Biotech, - Pharma, FDA, Rheumatology | Leave a comment

Is polio making a comeback?

Update November 13, 2018- Parents of children who died from this “polio-like” illness are accusing the

Posted in CDC, Congress, Infectious disease, Internal Medicine, Neurology, Neurosurgery, NIH, Pediatrics, Primary care medicine, Rheumatology | Leave a comment

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

May 23, 2017- interviewed by Steven E. Greer, MD We interviewed polumonologist Michael Wechsler, MD about his paper in the NEJM testing mepolizumab

Posted in - NEJM, National Jewish Health, Pulmonology, Rheumatology | Leave a comment